1h Free Analyst Time
The global parenteral nutrition market is expected to grow at a CAGR of 6.88% during 2021-2027. The increasing poverty at a global level and concern about nutritional health are the major factors that demand the parenteral nutrition supply. The factors that drive the market growth are increasing malnutrition in general and hospitalized patients. Malnutrition is a growing concern that requires a parenteral nutrition supply. The major targeted population is hospitalized patients, preterm birth, cancer patient, and other diseases that demand parenteral nutrition and gives a boost to the market growth at the global market. Speak directly to the analyst to clarify any post sales queries you may have.
Parenteral nutrition is also called the intravenous administration of nutrition, which includes carbohydrates, proteins, fat, electrolytes, mineral, fat, vitamins, water, and other trace elements. Parenteral nutrition (PN) is used to deliver nutritional supply to patients who cannot tolerate enteral or oral nutrition delivery. There are two types of parenteral nutrition: total and partial parenteral. Depending on the patient's conditions and nutritional health status, the patient can receive total or partial parenteral nutrition in healthcare settings.
MARKET TRENDS & DRIVERS
Availability of Standardized and Commercial Parenteral Nutrition Solutions
- The increasing demand for personalized and commercial medicine in the healthcare industry is a growing trend addressed in recent years. The growing preference for standardized and commercial parenteral nutrition solutions gives a new shape to the parenteral nutrition market.
- Standardized parenteral nutrition products are convenient and flexible for healthcare services it can be given to patients without compounding in-house. Standardized and commercial parenteral nutrition products can be sourced as institution-specific standardized formulations, patient-specific customized, or commercially available products. The demand for standardized and commercial parenteral nutrition has been increasing in recent years due to beneficiaries associated with the products. These solutions offer several advantages to healthcare organizations, including stability & compatibility and minimal manipulation.
Increasing Targeted Patient Population
- Parenteral nutrition treats and manages various chronic conditions, malnourished patient populations, and emergency medical conditions. Worldwide, the increasing patient population drives the demand for nutritional support in healthcare services such as hospitals, clinics, and home care settings. Globally, the increasing prevalence of chronic conditions is one of the major factors that drive the significant demand for hospitalization where patients demand nutritional support due to the increasing illness or inability to meet the nutritional demand. On another side, the increasing poverty led to various medical conditions and demand for parenteral conditions.
- Cancer is one of the leading causes of death accounted for at the global level. In 2020, more than 18 million cancer cases were registered worldwide. Among cancer patients, malnutrition is a common condition that requires external nutrition support. Around 1.8 million people with cancer die just due to malnutrition. The higher prevalence of malnutrition among cancer patients drives the parenteral nutrition market growth.
INDUSTRY RESTRAINTS
Complications Associated with Parenteral Nutrition
Parenteral nutrition is a complex procedure to feed the external nutritional support for the patients. Most hospitalized patients receive parenteral nutrition due to the hospital's associated malnutrition and medical condition. Both factors are challenging for parenteral nutrition delivery. The most vital complication of parenteral nutrition support is the failure to achieve the desired goals due to inadequate monitoring. Due to the higher risk of complications associated with parenteral nutrition, it is given less prominence than enteral nutrition, which hampers the parenteral nutrition market growth. The primary and major concerns related to parenteral nutrition are infection of the bloodstream from the atrophy of the digestive tract when it isn’t being used and IV catheter.SEGMENTATION INSIGHTS
INSIGHTS BY NUTRIENTS
The global parenteral nutrition market is segmented into macronutrients, automated compounds, and micronutrients by the nutrient category. The macronutrients segment accounted for a 66.65% higher market share in the parenteral nutrition market and dominated the other segment in 2021. Macronutrients include lipids and amino acids. Lipids and amino acids are majorly used ingredients in parenteral nutrition solutions as energy-dese solutions and support body function and rapidly improve body physics. Lipids and amino acids are used in parenteral nutrition as per their characteristics in improving nutritional health through parenteral nutrition. Moreover, the maximum number of products available in the market by manufacturers and market players are based on macronutrients, which further accelerates the macronutrient segment growth.
- The global parenteral nutrition market by automated compounds was valued at USD 1.35 billion in 2021. The advancement in automated compounds in parenteral nutrition recently becomes more popular in pediatric parenteral nutrition. Parenteral nutrition compounding is automated using volumetric pump systems in major hospitals and healthcare settings. In most US hospitals and healthcare settings, more than 65% of hospitals use automated compounding devices.
Segmentation by Nutrients
- Macronutrients
- Automated Compounds
- Micronutrients
INSIGHTS BY PATIENT TYPE
The parenteral nutrition market is segmented into the pediatric and adult segment by patient type. The pediatric segment accounts for a 55.05% major market share and is expected to dominate the adult segment during the forecast period. The significant number of the targeted preterm patient population, rising low birth weight concern, and malnutrition fuel the demand for parenteral nutrition supply over the adults. In addition, the advancement in trace elements and new products for pediatric parenteral nutrition accelerates segmental growth.Segmentation by Patient Group
- Pediatric Patient Group
- Adult Patient Group
INSIGHTS BY INDICATION
- The global parenteral nutrition market is segmented into short-term and long-term segments by indication. The short-term segment dominates the market with a 55.41% higher share. Globally, the increasing prevalence of cancer, metabolic disorders, gut failure, and malnutrition significantly drive the demand for healthcare services and receiving parenteral nutrition.
- By long-term indication, the global parenteral nutrition market was valued at USD 3.20 billion in 2021. Long-term parenteral nutrition is a highly demanding medical nutrition therapy delivered through the intravenous route for a long time as per the patient’s requirement. With the increasing prevalence of gastrointestinal disorders, patients go through several medications and treatments that impact the digestive system's functional ability and demand for parenteral nutrition. The recovery from digestive system injury or surgery takes significant time to get normal health and drives the high demand for long-term parenteral nutrition supply.
Segmentation by Indication
- Short-Term
- Long-Term
INSIGHTS BY END USER
- The hospital segment accounted for a 47.57% share of the parenteral nutrition market in 2021 and dominated the end-user segment. The rising prevalence of malnutrition, diseases-related malnutrition, and hospital-associated malnutrition conditions significantly demand parenteral nutrition. Hospitals are a primary and well-established infrastructure for a longer stay if the patient suffers from any medical condition or procedure illness. Baxter, the leading industry player, stated that around 2 million approximated hospitals in the US involve in malnutrition prevalence.
- The global parenteral nutrition market by ambulatory care settings was valued at USD 3.13 billion in 2021. In the ambulatory care settings segment, clinics and external healthcare services are included. In developing countries or emerging markets, malnutrition poses a significant cost burden on patients. So patients looking to avoid long hospital stays opt for other healthcare settings. In such a scenario, clinics and ambulatory care settings play a vital role in parenteral nutrition deliveries. Clinical nutrition is a major part of healthcare services for patients suffering from chronic illness. Also, the high-cost burden in a hospital setting for parenteral nutrition deliveries and longer stays change the patient preference for care to ambulatory care settings.
Segmentation by End-users
- Hospitals
- Ambulatory Care Settings
- Others
GEOGRAPHICAL ANALYSIS
- North America dominates the global parenteral nutrition market accounting for an industry share of 41.05%. The factors that drive the industry growth in the region are the high research expenditure by the companies, government authorities, and private entities in the nutrition sector that give the region significant access to parenteral nutrition services. In addition, the high healthcare expenditure and acceptance of home parenteral and other nutrition therapies across the US anticipated higher parenteral nutrition market growth in the region.
- APAC's parenteral nutrition market was valued at USD 2.09 billion in 2021. The region is a growing parenteral nutrition market with an increasingly aging population, research and development in clinical nutrition, and regional healthcare infrastructure growth. The prevalence of chronic disorders such as cancer, diabetes, gastrointestinal disorders, kidney failure, and cardiovascular diseases showed that the region's highest patient population demands care services and drives the parenteral nutrition market.
Segmentation by Geography
- APAC
- China
- India
- Japan
- South Korea
- Australia
- Europe
- Germany
- Italy
- Spain
- France
- UK
- North America
- US
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Turkey
- South Africa
- South Arabia
VENDOR LANDSCAPE
Baxter, B. Braun Melsungen, Baxter, Fresenius Kabi, JW Pharmaceutical, and Kelun Pharmaceuticals are some of the leading players in the parenteral nutrition market. These companies account for the higher market share and show high industry penetration by offering advanced and quality solutions. On the other hand, emerging industry players and new start-ups are trying to achieve a solid customer base and market expansion. The presence of emerging industry players positively influences the competition in the global parenteral nutrition market. The primary competition among the industry players accounted due to new product launches, emerging, and gold standard formulations.Key Company Profiles
- Baxter
- B. Braun Melsungen
- Fresenius Kabi
- JW Pharmaceuticals
- Sichuan Kelun Pharmaceuticals
Other Prominent Vendors
- Aculife
- Albert David
- Amanta Healthcare
- American Reagent
- BML PARENTERAL DRUGS
- Caritas Healthcare
- Eurofarma
- EuroLife Healthcare Pvt. Ltd.
- Farmoterapica
- Grifol
- ICU Medical
- Otsuka Pharmaceutical
- Soleo Health
- REVIV
- Pfizer
- Vifor Pharma
KEY QUESTIONS ANSWERED
1. How big is the parenteral nutrition market?2. What is the growth rate of the global parenteral nutrition market?
3. Which region holds the most prominent global parenteral nutrition market share?
4. Who are the key players in the global parenteral nutrition market?
5. What are the key driving factors for the growth of the parenteral nutrition market?
Table of Contents
1 Research Methodology2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market by Nutrients
4.3.2 Market by Indication
4.3.3 Market by Patient Group
4.3.4 Market by End-Users
4.3.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.1.1 Economic Impact of Malnutrition & Growth of Parenteral Nutrition
8 Premium Insights
8.1 Overview
9 Market Opportunities & Trends
9.1 Advances in Trace Elements for Parenteral Nutrition
9.2 Availability of Standardized and Commercial Parenteral Nutrition Solutions
9.3 Growth in Preference for Home Parenteral Nutrition
10 Market Growth Enablers
10.1 Increasing Prevalence of Chronic Disorders
10.2 Increasing Prevalence of Malnutrition
10.3 Increasing Target Patient Population
11 Market Restraints
11.1 Parenteral Nutrition Challenges in Preterm Infants and Children
11.2 Availability of Alternative Nutrition Care Methods
11.3 Complications Associated with Parenteral Nutrition
12 Market Landscape
12.1 Market Overview
12.1.1 Nutrients Insights
12.1.2 Patient Group Insights
12.1.3 Indication Insights
12.1.4 End-Users Insights
12.1.5 Geography Insights
12.2 Market Size & Forecast
12.3 Five Forces Analysis
12.3.1 Threat of New Entrants
12.3.2 Bargaining Power of Suppliers
12.3.3 Bargaining Power of Buyers
12.3.4 Threat of Substitutes
12.3.5 Competitive Rivalry
13 Nutrients
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Macronutrients
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Market by Geography
13.4 Automated Compounds
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Market by Geography
13.5 Micronutrients
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Market by Geography
14 Indication
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Short-Term
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Market by Geography
14.4 Long-Term
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Market by Geography
15 Patient Group
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.1 Pediatric
15.1.1 Market Overview
15.1.2 Market Size & Forecast
15.1.3 Market by Geography
15.2 Adult
15.2.1 Market Overview
15.2.2 Market Size & Forecast
15.2.3 Market by Geography
16 End-Users
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Hospitals
16.3.1 Market Overview
16.3.2 Market Size & Forecast
16.3.3 Market by Geography
16.4 Ambulatory Care Settings
16.4.1 Market Overview
16.4.2 Market Size & Forecast
16.4.3 Market by Geography
16.5 Others
16.5.1 Market Overview
16.5.2 Market Size & Forecast
16.5.3 Market by Geography
17 Geography
17.1 Market Snapshot & Growth Engine
17.2 Geographic Overview
18 North America
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Nutrients
18.3.1 Market Size & Forecast
18.4 Indication
18.4.1 Market Size & Forecast
18.5 Patient Group
18.5.1 Market Size & Forecast
18.6 End-Users
18.6.1 Market Size & Forecast
18.7 Key Countries
18.7.1 Us: Market Size & Forecast
18.7.2 Canada: Market Size & Forecast
19 APAC
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Nutrients
19.3.1 Market Size & Forecast
19.4 Indication
19.4.1 Market Size & Forecast
19.5 Patient Group
19.5.1 Market Size & Forecast
19.6 End-Users
19.6.1 Market Size & Forecast
19.7 Key Countries
19.7.1 China: Market Size & Forecast
19.7.2 Japan: Market Size & Forecast
19.7.3 India: Market Size & Forecast
19.7.4 South Korea: Market Size & Forecast
19.7.5 Australia: Market Size & Forecast
20 Europe
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Nutrients
20.3.1 Market Size & Forecast
20.4 Indication
20.4.1 Market Size & Forecast
20.5 Patient Group
20.5.1 Market Size & Forecast
20.6 End-Users
20.6.1 Market Size & Forecast
20.7 Key Countries
20.7.1 Germany: Market Size & Forecast
20.7.2 France: Market Size & Forecast
20.7.3 Uk: Market Size & Forecast
20.7.4 Italy: Market Size & Forecast
20.7.5 Spain: Market Size & Forecast
21 Latin America
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Nutrients
21.3.1 Market Size & Forecast
21.4 Indication
21.4.1 Market Size & Forecast
21.5 Patient Group
21.5.1 Market Size & Forecast
21.6 End-Users
21.6.1 Market Size & Forecast
21.7 Key Countries
21.7.1 Brazil: Market Size & Forecast
21.7.2 Mexico: Market Size & Forecast
21.7.3 Argentina: Market Size & Forecast
22 Middle East & Africa
22.1 Market Overview
22.2 Market Size & Forecast
22.3 Nutrients
22.3.1 Market Size & Forecast
22.4 Indication
22.4.1 Market Size & Forecast
22.5 Patient Group
22.5.1 Market Size & Forecast
22.6 End-Users
22.6.1 Market Size & Forecast
22.7 Key Countries
22.7.1 Turkey: Market Size & Forecast
22.7.2 South Africa: Market Size & Forecast
22.7.3 Saudi Arabia: Market Size & Forecast
23 Competitive Landscape
23.1 Competition Overview
23.2 Market Share Analysis
23.2.1 Baxter
23.2.2 B. Braun Melsungen
23.2.3 Fresenius Kabi
23.2.4 Jw Pharmaceutical
23.2.5 Sichuan Kelun Pharmaceutical Co. Ltd.
24 Key Company Profiles
24.1 Baxter
24.1.1 Business Overview
24.1.2 Product Offerings
24.1.3 Key Strategies
24.1.4 Key Strengths
24.1.5 Key Opportunities
24.2 B. Braun Melsungen
24.2.1 Business Overview
24.2.2 Product Offerings
24.2.3 Key Strategies
24.2.4 Key Strengths
24.2.5 Key Opportunities
24.3 Fresenius Kabi
24.3.1 Business Overview
24.3.2 Product Offerings
24.3.3 Key Strategies
24.3.4 Key Strengths
24.3.5 Key Opportunities
24.4 Jw Pharmaceutical
24.4.1 Business Overview
24.4.2 Product Offerings
24.4.3 Key Strategies
24.4.4 Key Strengths
24.4.5 Key Opportunities
24.5 Sichuan Kelun Pharmaceutical Co. Ltd.
24.5.1 Business Overview
24.5.2 Product Offerings
24.5.3 Key Strategies
24.5.4 Key Strengths
24.5.5 Key Opportunities
25 Other Prominent Vendors
25.1 Aculife
25.1.1 Business Overview
25.1.2 Product Offerings
25.2 Albert David
25.2.1 Business Overview
25.2.2 Product Offerings
25.3 Amanta Healthcare
25.3.1 Business Overview
25.3.2 Product Offerings
25.4 American Reagent
25.4.1 Business Overview
25.4.2 Product Offerings
25.5 Bml Parenteral Drugs
25.5.1 Business Overview
25.5.2 Product Offerings
25.6 Caritas Healthcare
25.6.1 Business Overview
25.6.2 Product Offerings
25.7 Eurofarma
25.7.1 Business Overview
25.7.2 Product Offerings
25.8 Eurolife Healthcare
25.8.1 Business Overview
25.8.2 Product Offerings
25.9 Farmoterapica
25.9.1 Business Overview
25.9.2 Product Offerings
25.10 Grifols S.A.
25.10.1 Business Overview
25.10.2 Product Offerings
25.11 Icu Medical
25.11.1 Business Overview
25.11.2 Product Offerings
25.12 Otsuka Pharmaceutical
25.12.1 Business Overview
25.12.2 Product Offerings
25.13 Soleo Health
25.13.1 Business Overview
25.13.2 Product Offerings
25.14 Reviv
25.14.1 Business Overview
25.14.2 Product Offerings
25.15 Pfizer
25.15.1 Business Overview
25.15.2 Product Offerings
25.16 Vifor Pharma
25.16.1 Business Overview
25.16.2 Product Offerings
26 Report Summary
26.1 Key Takeaways
26.2 Strategic Recommendations
27 Quantitative Summary
27.1 Market by Geography
27.2 Market by Nutrients
27.3 Market by Indication
27.4 Market by Patient Group
27.5 Market by End-User
27.6 Nutrients: Market by Geography
27.6.1 Macronutrients: Market by Geography
27.6.2 Automated Compounds: Market by Geography
27.6.3 Micronutrients: Market by Geography
27.7 Indication: Market by Geography
27.7.1 Short-Term: Market by Geography
27.7.2 Long-Term: Market by Geography
27.8 Patient Group: Market by Geography
27.8.1 Pediatric: Market by Geography
27.8.2 Adult: Market by Geography
27.9 End-Users: Market by Geography
27.9.1 Hospitals: Market by Geography
27.9.2 Ambulatory Care Centers: Market by Geography
27.9.3 Others: Market by Geography
28 Appendix
28.1 Abbreviations
Companies Mentioned
- Baxter
- B. Braun Melsungen
- Fresenius Kabi
- JW Pharmaceuticals
- Sichuan Kelun Pharmaceuticals
- Aculife
- Albert David
- Amanta Healthcare
- American Reagent
- BML PARENTERAL DRUGS
- Caritas Healthcare
- Eurofarma
- EuroLife Healthcare Pvt. Ltd.
- Farmoterapica
- Grifol
- ICU Medical
- Otsuka Pharmaceutical
- Soleo Health
- REVIV
- Pfizer
- Vifor Pharma
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 289 |
| Published | February 2023 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD | $ 7.18 Billion |
| Forecasted Market Value ( USD | $ 10.7 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
